DelveInsight

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.


Research Reports By DelveInsight

Found 2368 publications
Neuroendocrine Tumors (NETs) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 125 pages
Neuroblastoma (NB)- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 60 pages
Endometriosis- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 50 pages
CD40 Agonist - Pipeline Insight, 2018 US$ 1,250.00 US$ 1,000.00 Oct, 2018 79 pages
Retinal Degeneration - Pipeline Insight, 2018 US$ 1,500.00 US$ 1,200.00 Oct, 2018 217 pages
Factor VIII Inhibitor - Pipeline Insight, 2018 US$ 1,250.00 US$ 1,000.00 Oct, 2018 49 pages
Eosinophilic Esophagitis- Pipeline Insight, 2018 US$ 1,250.00 US$ 1,000.00 Oct, 2018 63 pages
ADA-SCID - Competitive Landscape and Market Insight, 2018 US$ 4,750.00 US$ 3,800.00 Oct, 2018 50 pages
Von Willebrand Disease (VWD)- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 69 pages
Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018 US$ 7,500.00 US$ 6,000.00 Oct, 2018 147 pages
Primary Hyperoxaluria (PH) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 73 pages
Dendritic Cancer Cell Therapy- Pipeline Insights, 2018 US$ 1,500.00 US$ 1,200.00 Oct, 2018 160 pages
Hepatocellular Carcinoma (HCC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 92 pages
Thrombocytopenia - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 143 pages
Spasticity - Epidemiology Forecast - 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 78 pages
Tuberous Sclerosis Complex (TSC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 69 pages
Migraine - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00 Oct, 2018 120 pages
Yondelis - API Insight, 2018 US$ 500.00 US$ 400.00 Oct, 2018 32 pages
Uveal Melanoma - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00 Oct, 2018 120 pages
Entyvio- Drug Insight, 2018 US$ 1,000.00 US$ 800.00 Oct, 2018 39 pages
Multiple Sclerosis  -Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 102 pages
Endometriosis - Market Insight, Epidemiology and Market Forecast - 2027 US$ 6,250.00 US$ 5,000.00 Oct, 2018 100 pages
Degenerative Disc Disease - Pipeline Insight, 2018 US$ 1,250.00 US$ 1,000.00 Oct, 2018 75 pages
Acute Renal Failure (ARF)- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 60 pages
Hepatitis D - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00 Oct, 2018 135 pages
Genital Herpes - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 54 pages
Portal Hypertension- Pipeline Insights, 2018 US$ 1,250.00 US$ 1,000.00 Oct, 2018 75 pages
Pulmonary Arterial Hypertension - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 50 pages
Cinryze - Drug Insights, 2018 US$ 1,000.00 US$ 800.00 Oct, 2018 34 pages
Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00 Oct, 2018 60 pages
Narcolepsy - Pipeline Insight, 2018 US$ 1,250.00 US$ 1,000.00 Oct, 2018 76 pages
1 2 3 4 5 ... 48
Skip to top

Analytics & News by DelveInsight